These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32521135)

  • 41. Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.
    Bevilacqua E; Jani JC; Letourneau A; Duiella SF; Kleinfinger P; Lohmann L; Resta S; Cos Sanchez T; Fils JF; Mirra M; Benachi A; Costa JM
    Fetal Diagn Ther; 2019; 45(5):302-311. PubMed ID: 29898450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fetal alcohol syndrome associated with trisomy 21.
    Bingol N; Fuchs M; Iosub S; Kumar S; Stone RK; Gromisch DS
    Alcohol Clin Exp Res; 1987 Feb; 11(1):42-4. PubMed ID: 2952028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal care for children with Down syndrome in India.
    Verma IC; Kabra M; Gangakhedkar AK
    Indian J Pediatr; 1996; 63(1):121-6. PubMed ID: 10829977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [PrenaTest].
    Velev R; Mircheva M
    Akush Ginekol (Sofiia); 2013; 52(2):60-1. PubMed ID: 23807983
    [No Abstract]   [Full Text] [Related]  

  • 45. Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?
    Bianchi DW; Oepkes D; Ghidini A
    Prenat Diagn; 2014 Jan; 34(1):6-11. PubMed ID: 24002925
    [No Abstract]   [Full Text] [Related]  

  • 46. [Noninvasive screening for trisomy 21].
    Hurst S
    Rev Med Suisse; 2015 Sep; 11(484):1626-7. PubMed ID: 26502626
    [No Abstract]   [Full Text] [Related]  

  • 47. [Foetal therapy for Down syndrome: a pro-active ethical reflection].
    de Wert GM; Dondorp WJ
    Ned Tijdschr Geneeskd; 2016; 160():D307. PubMed ID: 27334087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive value of the triple screening test for the phenotype of Down syndrome.
    Tanski S; Rosengren SS; Benn PA
    Am J Med Genet; 1999 Jul; 85(2):123-6. PubMed ID: 10406664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood?
    van Lith JM; Benacerraf BR; Yagel S
    Prenat Diagn; 2011 Mar; 31(3):231-4. PubMed ID: 21374636
    [No Abstract]   [Full Text] [Related]  

  • 51. Dynamics in prevalence of Down syndrome in children with congenital heart disease.
    Pfitzer C; Helm PC; Rosenthal LM; Berger F; Bauer UMM; Schmitt KR
    Eur J Pediatr; 2018 Jan; 177(1):107-115. PubMed ID: 29127498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnosis and management of Down syndrome.
    Agarwal Gupta N; Kabra M
    Indian J Pediatr; 2014 Jun; 81(6):560-7. PubMed ID: 24127006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-free DNA screening for new indications.
    Papageorghiou AT
    BJOG; 2023 May; 130(6):545. PubMed ID: 37045609
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y; Sun N; Wang F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
    J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood test for Down's syndrome is safe and effective, say researchers.
    Limb M
    BMJ; 2015 Jun; 350():h3126. PubMed ID: 26054574
    [No Abstract]   [Full Text] [Related]  

  • 59. Reflex antenatal DNA screening for Down syndrome.
    Wald NJ; Huttly WJ; Bestwick JP; Aquilina J; Peregrine E
    Prenat Diagn; 2015 Nov; 35(11):1154. PubMed ID: 26211510
    [No Abstract]   [Full Text] [Related]  

  • 60. Imaging single DNA molecules for high precision NIPT.
    Dahl F; Ericsson O; Karlberg O; Karlsson F; Howell M; Persson F; Roos F; Stenberg J; Ahola T; Alftrén I; Andersson B; Barkenäs E; Brandner B; Dahlberg J; Elfman S; Eriksson M; Forsgren PO; Francois N; Gousseva A; Hakamali F; Janfalk-Carlsson Å; Johansson H; Lundgren J; Mohsenchian A; Olausson L; Olofsson S; Qureshi A; Skarpås B; Sävneby A; Åström E; Öhman O; Westgren M; Kopp-Kallner H; Fianu-Jonasson A; Syngelaki A; Nicolaides K
    Sci Rep; 2018 Mar; 8(1):4549. PubMed ID: 29540801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.